UNSPSC 51191553: Indapamide

This classification denotes a thiazide diuretic with the molecular formula C16H16ClN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F089I0511L, chemically known as 4-chloro-n-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoyl-benzamide but generally known as indapamide, which bears US NIH Compound Identifier 3702. European Medicines Agency schedules Indapamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08169MIG.

UNSPSC 51191553 Indapamide is a Commodity code that represents pharmaceutical products, but the recent state and local opportunities tagged under it reflect a broader procurement pattern of chemical supplies and medical/pharmaceutical services for municipal and state institutional operations rather than the specific antihypertensive drug. State and local buyers soliciting under this code include water utilities, departments of corrections, and county environmental agencies acquiring chemicals for treatment operations, parenteral pharmaceutical products and services for correctional healthcare, and valve components and repair services for wastewater infrastructure—indicating that the code may be capturing miscategorized industrial chemical and medical supply purchases alongside its nominal scope. Issuing bodies span state health and corrections agencies, county environmental departments, and municipal utilities.

Recent opportunities show geographic activity across Florida, Washington, and Connecticut. The Washington State Department of Corrections issued an RFQ (due October 7, 2026) for parenteral products, services, and equipment to supply eight correctional facilities statewide, with DOC anticipating multiple contractor awards across three regions (West, Central, and East) and an initial contract term through June 30, 2030; the scope includes parenteral nutrition solutions, intravenous products, and controlled substances with strict 24-hour delivery requirements for TPN bags and 8-hour requirements for other parenteral stock. Broward County, Florida posted an RFI (due September 29, 2026) on DeZurik/APCO valves, parts, and repair services for wastewater treatment infrastructure to test supplier availability prior to potential sole-source designation. The City of Meriden, Connecticut solicited bids for sodium bisulfite chemical supply for its Water Pollution Control Facility (due July 29, 2026). The code shows activity but with misalignment between its nominal pharmaceutical focus and the actual procurements being tagged to it.